Authors
Latest:
Lilly Makes Tirzepatide Single-Dose Vials Available as Self-Pay Option at 50% DiscountVials of tirzepatide 2.5 mg and 5 mg will be available with a prescription for the labeled drug through LillyDirect after completing a multistep verification process, the company said.
Latest:
Prenatal Exposure to Antibiotics May Increase Risk for Long-Term Health Problems in ChildrenThe potential adverse outcomes include asthma, food allergies, cerebral palsy, and cancer, according to a recent systematic review and meta-analysis.
Latest:
Roflumilast Associated with Increase in 5-Year Mortality Risk in Patients with COPDIn a large study of patients with COPD, a small increase in 5-year all-cause mortality risk was observed among those using roflumilast.
Latest:
Telemedicine vs In-person Care: In Addiction Medicine, Options are KeyCOVID-19 has dealt in-person addiction treatment a blow, but the chief medical officer of Groups Recover Together tells a telemedicine success story with a hybrid ending.
Latest:
Texting Patients? Don't Make these HIPAA MistakesTrain your staff well, says this expert in business texting solutions, and make sure to develop and use appropriate checks and balances.
Latest:
Final Thoughts on Identifying and Managing Patients with T1DPanelists discuss how early identification of Type 1 diabetes through screening programs, combined with emerging therapies like teplizumab, offers new opportunities for intervention and improved patient outcomes in at-risk populations.
Latest:
Vaccination Strategies Practice Pearls And Key Take AwaysDrs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.
Latest:
For Unknown Causes of Kidney Disease, Genetic Testing Holds PromiseA recent American Kidney Fund survey of 300 primary care and specialty clinicians found ~15% of their patients had kidney disease of unknown origin.
Latest:
Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two TrialsAcross two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.
Latest:
Take-home Messages for Acute Pain ManagementBenjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Latest:
Guidance for PCPs: Streamlining Menopause CarePanelists discuss strategies for simplifying complex information for primary care physicians (PCPs), provide tips on how PCPs can effectively communicate evidence-based treatment options to patients, and outline actionable points and key takeaways to enhance patient care in managing menopause symptoms.
Latest:
The CMS CED Policy Limits Treatment for Early Alzheimer's Disease: What It Is and How It WorksThe coverage with evidence development (CED) policy requires enrollment in an active clinical trial for an adult to be eligible for Medicare coverage of treatment for Alzheimer's disease.
Latest:
Cannabis: An "Ins and Outs" Primer for Primary CareA concise update on legal status, FDA approvals, patient safety, and public perception.
Latest:
Distinct Patterns of BP in Early Gestation Predict Hypertensive Disorders: StudyInvestigators identified 6 blood pressure patterns that, when combined with other risk factors, accurately stratified risk of hypertensive disorders of pregnancy.
Latest:
Final Pearls and Takeaways for Testing and Managing CKDExperts wrap up their discussion of emerging chronic kidney disease tests and treatments with key takeaways for providers and patients.
Latest:
FDA Ruling on National Breast Density Notification for Mammography Reports FinalizedBeginning on Sept 24, 2024, all women must be notified of their breast density status in mammography reports and encouraged to pursue supplemental screening.
Latest:
Two Biosimilars to Denosumab Win FDA Approval as Amgen and Sandoz Go to CourtBiosimilars Wyost and Jubobonti were approved as interchangeable for Xgeva and Prolia but launch will depend on the outcome of litigation between reference product manufacturers.
Latest:
Managing Atopic Dermatitis in Special Populations: Expert Insights for Primary CareIn an interview at AAD 2025, Katrina Abuabara, MD, stressed the importance of collaboration between primary care physicians and dermatologists.
Latest:
First-Ever MDMA-Assisted Therapy for PTSD is Granted FDA Priority ReviewIf the FDA approves the treatment, it will be the first-ever MDMA-assisted therapy and psychedelic-assisted therapy. The PDUFA date is set for August 11, 2024.
Latest:
The Importance of Connecting Patients with ADPKD with Each OtherPeer mentor programs can provide support for patients, especially when it comes to family planning and parenthood.
Latest:
Michael A. Weber, MD, on aprocitentan approval: A new approach to managing hypertensionMichael A. Weber, MD, an investigator in the PRECISION study, discusses the newly FDA approved drug aprocitentan (Tryvio), and its promise for helping patients with treatment-resistant hypertension.
Latest:
Is Technology the Answer to Revitalized Primary Care?Health care leaders increasingly are looking to technology for solutions to the challenges facing primary care.
Latest:
Refining Diabetes Care for Older Adults: Expert Insights on Deprescribing, Streamlining Treatment, and Key Practice PearlsExperts on diabetes provide insights gleaned from the SIMPLE study and outline patient factors that inform treatment decisions.
Latest:
Coronary Artery Calcium Scoring: 7 Questions for Primary CareHow current are you on CAC and its place in CVD risk assessment? This short quiz will reveal your score.
Latest:
Efficacy of Latest COVID-19 VaccinesExperts discuss the efficacy of the latest vaccines against currently circulating strains of COVID-19, commenting on how long immunity lasts from these vaccines.
Latest:
JiaDe Yu, MD: When to Refer Pediatric Patients with Suspected Contact DermatitisIn an interview at AAD 2025, Dr Yu emphasized the importance of managing contact dermatitis early and effectively to prevent long-term complications.
Latest:
The State of Vaccine Willingness in the US: A Primary Care and an Infectious Disease Physician DiscussWell-known ID specialist Bill Schaffner, MD, and active primary care educator Chuck Vega, MD, offer thoughts on how to get shots into arms in the 2023-2024 respiratory virus season.
